Related Experiment Videos
CD44 expression in human meningiomas: an immunohistochemical analysis
Iwona Lewy-Trenda1, Aleksandra Omulecka, Janusz Janczukowicz
1Chair of Pathomorphology, Medical University, Lódź. mtrenda@poczta.onet.pl
Summary
CD44 molecule expression is stronger in atypical meningiomas compared to benign types. This suggests CD44
Area of Science:
- Neuro-oncology
- Molecular biology
- Cell biology
Background:
- CD44 molecules are crucial for cell adhesion, cell-extracellular matrix interactions, and invasive growth.
- Understanding CD44 expression patterns can provide insights into meningioma behavior.
Purpose of the Study:
- To investigate and compare CD44 expression levels in atypical (G2) and various subtypes of benign (G1) meningiomas.
- To determine the correlation between CD44 expression and meningioma grade.
Main Methods:
- Immunohistochemical staining of CD44 antibody on paraffin-embedded tissue sections from 61 meningioma patients.
- Analysis of CD44 expression intensity (multifocal and diffuse) in atypical meningiomas (G2) and benign subtypes (transitional, meningothelial, fibroplastic - G1).
Main Results:
- Strong CD44 expression was observed in atypical meningiomas (G2).
- No CD44 expression was found in fibroplastic meningiomas, while moderate expression was noted in transitional and meningothelial subtypes (G1).
- Statistically significant differences in CD44 expression were identified between G2 and G1 meningiomas.
Conclusions:
- CD44 expression levels differ significantly between atypical and benign meningiomas.
- Elevated CD44 expression in atypical meningiomas supports its role in the invasive growth potential of neoplastic cells.
- The study highlights the potential involvement of CD44 in meningioma progression.